We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Continuous Heart Monitor Watch Improves AF Screening

By HospiMedica International staff writers
Posted on 29 Oct 2020
A physician-prescribed wearable solution provides continuous cardiac monitoring to detect atrial fibrillation (AF) on demand during the day, and automatically overnight.

The Livmor (Frisco, TX, USA) Halo AF Detection System is a wearable solution that consists of a proprietary algorithm that filters and detects irregular pulse rhythm suggestive of AF from photoplethysmograph (PPG) data, a patient user interface that notifies the patient of data collection, and a physician user interface that alerts when an irregular pulse rhythm is detected. More...
Device software interfaces with the LIVMOR Halo+ Home Monitoring System and a compatible Samsung (Seoul, Korea) Halo smartwatch to capture PPG data and sync to servers.

During the night, the Halo watch intermittently monitors for irregular heart rhythm via the Halo+ Home Monitoring System while the user is at rest. PPG signals recorded by the Halo Watch are subsequently analyzed when WiFi connectivity is available. The recording session signal is first assessed for quality before being analyzed. If a signal is suggestive of AF is detected, it is flagged for physician review in the Linvmor HeartView physician portal. In recent clinical studies, The Halo was 100% sensitive and 93% specific in identifying AF.

“Our Halo AF detection algorithms, deployed as an integrated part of the Livmor Halo+ Home Monitoring system, serves as a foundational cornerstone in our Samsung-based digital health platform,” said Ken Persen, founder and CEO of Livmor. “Starting today, medical professionals across the US can prescribe our Livmor Halo, a patient-engaging and extendable system, to their at-risk patients. This is major step toward achieving our vision of a transformative patient-provider ecosystem that more proactively prevents, detects, and manages chronic conditions.”

“With the increased need for remote care and monitoring, Samsung is committed to working with strategic partners to develop innovative digital health solutions,” said Taher Behbehani, general manager and head of mobile B2B at Samsung Electronics America. “We are thrilled that Livmors’s secure AF detection monitor on Samsung wearables has achieved this significant milestone, helping clinicians reach even more patients with potentially life-saving technology.”

As the heart pumps blood to the periphery of the body, a pressure pulse is created which distends the arteries and arterioles in the subcutaneous tissue. The change in volume caused by the pressure pulse is detected by illuminating the skin with a light-emitting diode (LED) and then measuring the amount of light either transmitted or reflected to a photodiode, thus generating a PPG.



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.